95 related articles for article (PubMed ID: 15566367)
1. Implication of SOCS-1 gene methylation in acute myeloid leukaemia.
Watanabe D; Naka T; Kishimoto T
Br J Haematol; 2004 Dec; 127(5):608-9. PubMed ID: 15566367
[No Abstract] [Full Text] [Related]
2. How frequent is SOCS1 methylation in acute myeloid leukaemia?
Chim CS; Kwong YL
Br J Haematol; 2004 Dec; 127(5):609-11. PubMed ID: 15566368
[No Abstract] [Full Text] [Related]
3. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the SOCS-1 gene by CpG methylation?
Melzner I; Möller P
Blood; 2003 Aug; 102(4):1554-5; author reply 1555. PubMed ID: 12900355
[No Abstract] [Full Text] [Related]
7. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
[TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia.
Liu TC; Lin SF; Chang JG; Yang MY; Hung SY; Chang CS
Br J Haematol; 2003 Nov; 123(4):654-61. PubMed ID: 14616969
[TBL] [Abstract][Full Text] [Related]
12. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
13. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis.
Hibi K; Kodera Y; Ito K; Akiyama S; Nakao A
Dis Colon Rectum; 2005 Jun; 48(6):1282-6. PubMed ID: 15793636
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
Jost E; do O N; Dahl E; Maintz CE; Jousten P; Habets L; Wilop S; Herman JG; Osieka R; Galm O
Leukemia; 2007 Mar; 21(3):505-10. PubMed ID: 17230231
[TBL] [Abstract][Full Text] [Related]
18. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
[TBL] [Abstract][Full Text] [Related]
19. SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma.
Depil S; Saudemont A; Quesnel B
Leukemia; 2003 Aug; 17(8):1678-9. PubMed ID: 12886263
[No Abstract] [Full Text] [Related]
20. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
Babu S; Kumaraswami V; Nutman TB
Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
